Merck Gets Favorable Opinion From CHMP For Its ZEPATIER By: Benzinga via Benzinga May 27, 2016 at 08:38 AM EDT Merck & Co., Inc. (NYSE: MRK) disclosed Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European ... Read More >> Related Stocks: Merck & Co